Identifying barriers to treatment of childhood rhabdomyosarcoma in resource-limited settings: A literature review

Abstract

We performed a literature review to examine barriers for rhabdomyosarcoma treatment in low-resource settings, and identified 29 articles from 14 middle-income countries, with none from low-income countries. Notable findings included inconsistent use of local control modalities, lack of diagnostics in some settings, and high rate of abandonment specifically in low middle-income countries. Reported limitations included lack of surgical expertise and/or radiation therapy, advanced stage of disease, and absence of health insurance. Although very poor outcomes were prevalent in several settings, good outcomes were achievable in others when multidisciplinary therapy and financial coverage of medical care were made available. © 2019 Wiley Periodicals, Inc.

Description

Keywords

Childhood rhabdomyosarcoma, Lmic, Outcomes, Resource-limited setting, Umic, Child, Developing countries, Humans, Insurance, health, Neoplasm staging, Rhabdomyosarcoma, Carboplatin, Cisplatin, Cyclophosphamide, Dactinomycin, Doxorubicin, Epirubicin, Etoposide, Ifosfamide, Vincristine, Cancer combination chemotherapy, Cancer control, Cancer radiotherapy, Cancer surgery, Child health insurance, Childhood cancer, Clinical competence, Event free survival, Failure free survival, Financial management, Health care availability, Human, Low income country, Medical care, Middle income country, Multidisciplinary team, Overall survival, Priority journal, Resource management, Review, Survival rate, Treatment planning, Treatment refusal, Cancer staging, Developing country, Economics, Health insurance

Citation

Endorsement

Review

Supplemented By

Referenced By